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INTRODUCTION
Amino acidopathies (AA) and organic acidurias (OA) are
single gene inherited metabolic disorders (IMDs) due to
absolute or relative deficiency of specific enzyme or co-
enzyme.1 This leads to accumulation of toxic
metabolites, which manifest as clinical and biochemical
abnormalities. They are mostly inherited as autosomal
recessive (AR) trait.2 The IMDs are rare diseases with
individual incidence of less than 1 per 100,000 births;
but as a group, the incidence may approach 1 in 800 to
2500 births.3,4
Hutchesson et al. reported 100 times higher incidence of
tyrosinaemia type I and non-ketotic hyperglycinemia
(NKH) in Pakistani population as compared to the North-
West Europeans in UK. Authors reported a collective
frequency of 1:318 for IMDs in Pakistani population in
West Midlands, UK.5
Pakistan has a high infant mortality rate of 57.48
deaths/1,000 live births and ranks third highest among
Asian countries. It is also world's seventh most-populous
country with an estimated population of over
196,174,380 in 2015, with 33% of the population below
the age of 15 years. Sixty percent of all marriages are
consanguineous.6 The burden of IMDs is expected to be
high in Pakistan due to high consanguinity rate but exact
data is lacking. Newborn screening for any IMD does not
exist at national level. The healthcare system is mainly
hospital-based with ineffective primary health care
facilities. Most deliveries are attended by traditional birth
attendants at home.
Diagnosis of IMDs in Pakistan has been challenging due
to resource constraints and limited clinical and technical
expertise. From 2008-12, all diagnostic tests were out-
sourced, as there was no local IMDs diagnostic facility.
During this period, 85 patients were diagnosed.7 Later,
the local diagnostic Biochemical Genetics Laboratory (BGL)
was established at The Aga Khan University Hospital
(AKUH), Karachi. The burden of IMD in this part of the world
is not known and the aim of this study was to determine
the frequency of various OA and AA in high-risk patients.
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ABSTRACT
Objective: To determine the frequency of organic acidurais (OA) and amino acidopathies (AA) in selected high-risk
patients screened in two years. 
Study Design: Retrospective Observational study.
Place and Duration of Study: The Aga Khan University Hospital (AKUH), Karachi, from January 2013 to December 2014.
Methodology: Patients with OA and AA were included in the study and patients with IMDs other than OA and AA were
excluded. Amino acids and organic acids were analyzed on high performance liquid chromatography and gas
chromatography-mass spectrometry respectively. Clinical data and chromatograms of patients screened for IMDs were
reviewed by chemical pathologist and metabolic physician.
Results: Eighty-eight cases (4.7%) were diagnosed including 41 OA (46.5%), 28 AA (31.8%) and 19 others (21.5%) from
1,866 specimens analyzed. Median age of the patients was 1.1 years, with high consanguinity rate (64.8%). Among OA,
methyl CoA mutase deficiency was diagnosed in 9 (10.2%) and was suspected in 2 (2.3%) cases. Five (5.7%) cases of
MHBD (2-methyl-3-hydroxybutyryl-CoA), 4 (4.5%) each of PPA (propionic aciduria) and HMG-CoA lyase deficiency,
3 (3.4%) cases each of IVA (isovaleric aciduria), multiple carboxylase deficiency, fructose-1, 6-biphosphatase deficiency,
fumarase deficiency, GA-1 (glutaric aciduria type 1) and 2 (2.3%) cases of EMA (ethyl-malonic aciduria). AA included
8 (9.1%) cases of MSUD (maple syrup urine disease), 6 (6.8%) cases of CBS (cystathionine beta-synthetase) and UCDs
(urea cycle disorders) each, 5 (5.7%) cases of hyperphenylalaninemia and 3 (3.4%) cases of hyperprolinemia were
reported. Other inherited metabolic disorders included: 9 (10.2%) cases of intracellular cobalamin defects, 2 (2.3%) cases
each of alkaptonuria, Canavan's disease, SUCL (succinate CoA ligase) deficiency, and 1 (1.1%) case each of DPD
(dihydropyrimidine) deficiency, GA-2, NKH (non-ketotic hyperglycinemia), AADC (aromatic amino acid decarboxylase)
deficiency.
Conclusion: This study presents frequency of OA and AA in the high-risk Pakistani pediatric population analyzed locally.
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METHODOLOGY
This retrospective observational study was conducted at
BGL in the Section of Clinical Chemistry, Department of
Pathology and Laboratory Medicine, AKUH-K from
2013-14. All patients with high clinical suspicion of OA
and AA were included in the study on samples received
from all over Pakistan through its 200 Phlebotomy
Centers. All patients with IMDs other than OA and AA,
like glycogen storage disorders, lysosomal storage
disorders, peroxisomal disorders, and mitochondrial
disorders were excluded from the study. A retrospective
review of AA and OA data was done. The study was
exempted from ethical approval by the Ethical Review
Committee of the Hospital (3654-Path-ERC-15). For
amino acid chromatography, 3-4 ml of blood samples
were collected in lithium heparin tube or 0.5 ml CSF in
sterile container; and for organic acid analysis, 2-5 ml
urine was collected in preservative-free container.
Samples were sent to BGL after centrifugation from
outreach phlebotomy centers and transported in dry ice,
according to the standard protocol. All samples were
stored at -20°C prior to analysis. A questionnaire
comprising of clinical and biochemical information was
filled for AKUH-K in-patient and out-patient. Similar
questionnaire was filled for samples received at
phlebotomy centers of AKUH spread across Pakistan.
The amino acids quantification tests were performed by
Cation-Exchange HPLC on Biochrom 30+ model
440/570 nm, using lithium column diameter 4.6 mm.
Standard, control and specimens (plasma and urine)
were deproteinized with sulfosalicylic acid (10%) and nor
leucine was added as internal standard, whereas
deproteinization was not performed for CSF specimens.
The column eluent was mixed with ninhydrin reagent,
forming colored compound and the amount of color
produced was directly proportional to the quantity of
amino acids present in the sample. Each colored
compound was determined at 440 nm for hydroxypoline
and proline, and rest of the AAs were estimated at
570 nm. The results were analyzed by EZ chrome
software version 3.31.8
Urine organic acids samples were analyzed by Gas
Chromatography Mass Spectrometry (GCMS) (Model
7890 / 5975, Agilent Technologies Santa Clara, CA).
Estimation of urine creatinine (mmol/l) was done in all
the samples. Organic acids were extracted from specimens
by liquid-liquid extraction after mixing the internal
standard solution (3, 3 dimethyl glutaric acid), followed
by oximation, extraction and derivatization.8,9 Eluent was
analyzed with mass detection on scan mode data acquisition,
whereas quantification of succinylacetone was done on
SIM mode data acquisition. The data generated from
mass detector was analyzed by Chem station software
with the help of libraries, like ORGASID, ACID97 and NIST.
Quality control, validation and proficiency testing
validation for amino acids and organic acids were
performed, according to Clinical and Laboratory Standards
Institution guidelines at optimization of assays. Precision,
accuracy, carry over, analytical measurement range/
linearity and lot to lot verification were validated. We
used commercially available quality controls (ClinChek 1
and 2 and SKML) and ran two levels of controls with
every batch of 10 samples. BGL also participate in
proficiency testing surveys from European Research
Network for Evaluation and Improvement of Screening,
Diagnosis and Treatment of Inherited Disorders of
Metabolism (ERNDIM) and College of American
Pathologists (CAP) of plasma amino acids, urine organic
acids and succinylacetone, since its inception.
AA were diagnosed on the pattern of abnormalities
resulting from deranged quantification of amino acids
specific to disorders.10 Diagnoses of OA were confirmed
by disease specific urinary metabolites on chromatogram.11
One thousand, eight hundred and sixty-six specimens
were analyzed at BGL during 2013-14. Out of this, 88
positive cases of OA and AA were reviewed by Chemical
Pathologist and Metabolic Physician before releasing
final result.
Statistical Package for Social Sciences version 21 was
used to analyze the data. Frequencies and percentages
were calculated for gender, consanguinity, sibling
deaths, geographical distribution of IMDs, and clinical
presentations. Different OA, AA and other IMDs were
identified and frequencies and percentages were
analyzed for each specific IMD. Data of age distribution
was skewed so median value was reported along with
interquartile ranges.
RESULTS
Eighty-eight cases (4.7%) were diagnosed with IMDs
from 1866 specimens analyzed over the 2 years period
from all over the country. The geographical distribution
of IMD cases was 59 from Sindh (67%), 22 from Punjab
(25%), 04 from Khyber Pakhtunkhwa (4.5%), and 03
from Baluchistan (3.4%).
Median age was 1.1 years (IQR 2-4 years). More than
half were males 50 (56.8%). About two-thirds (64.8%) of
the patients were born to consanguineous parents. Most
frequent clinical presentations were lethargy (n=39,
44%), developmental delays (34, 39%), poor feeding
(n=34, 39%) and vomiting (n=28, 32%). Other
presentations were hypotonia (n=24, 28%), mental
retardation and fever (n=21, 24% each), and seizures
and failure to thrive (n=13, 15% each). Most of the
patients had combination of the mentioned symptoms
and signs. Developmental delays were more frequently
noted in infants, whereas metabolic decompensation
was more frequent in 1-5 years age group.
Forty-one patients (47%), were reported with OA.
Twenty-eight patients (32%) were reported to have
amino acidopathies and are summarized in Table I.
Nineteen other IMDs (21.6%) identified included:
intracellular cobalamin defects, alkaptonuria, canavan's
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disease, succinate CoA ligase (SUCL) deficiency,
dihydropyrimidine (DPD) deficiency, aromatic amino
acid decarboxylase (AADC) deficiency, glutaric aciduria
type 2 (GA-2), and non-ketotic hyperglycinemia (NKH).
DISCUSSION
This is a novel data from Pakistan, which shows
frequency of OA, AA and other IMDs established through
local diagnostic facility. Testings for OA, AA and other
IMDs in previously published five studies were sent
abroad for diagnostic purposes.7,12-15 This is cumber-
some as critical time is lost in procuring the results,
which delays the timely acute treatment; thus results in
either morbidity or mortality.
These studies showed that mostly the patient presented
with acute metabolic decompensation and neurological
manifestations. Three studies reported increased
frequency of OA, UCDs and NKH in Pakistani
population.12-14 According to Cheema et al.15, the most
frequent metabolic disorders were glycogen storage
disorders, gaucher disease, galactosemia and MPS as
compared to other IMDs. This major difference in
frequency could be due to the fact that this study was
conducted at the gastroenterology and hepatology
department, where mostly the patient present with liver
manifestations.
Afroze et al. reported 85 patients with IMD in 5 years
period from 2008-2012 diagnosed at AKUH-K, of which
47 were OA and AA. During that period, all diagnostic
tests were outsourced to IMR, Malaysia.7 After the local
availability of the diagnostic tests for the OA and AA, the
number of diagnosis made in 2 years period is almost
double the number of OA and AA that were diagnosed in
5 years period when only the clinical service was available.
This highlights the fact that the easy accessibility of a
local diagnostic facility to physicians and patients leads
to more patients being diagnosed and eventually results
in timely management of patients with IMDs.
In this study of high-risk patients, it was found that the
most common OA in the population was MMA, followed
by MHBD, PPA and HMG CoA lyase deficiency. In AA;
MSUD, CBS deficiency and UCDs were most frequent.
Hori et al. from Japan analyzed 4,653 patients and
reported 79 (70%) cases of OA and 21 (19%) cases of
AA, performed on GC-MS. The most common disorder
was MMA, followed by PPA, OTCD, and multiple
carboxylase deficiency.16 This data is similar to the
frequencies presently identified in the local population.
Tan et al. from Singapore analyzed 3,656 patients and
reported 41 (32%) cases of OA, performed on GC-MS;
and 48 (37%) cases with AA, performed on amino acid
analyzer.The most common OAs were GA-2, PPA, and
MMA.17 In their study, AAs disorders identified were
OTCD, phenylketonuria, MSUD and NKH. Thong et al.
from Malaysia analyzed 13,500 patients and reported 98
(37%) cases with OA, performed on GC-MS; and 132
(50%) cases with AA, performed through the ion-
exchange HPLC.8
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Table I: Frequency of IMDs reported from Biochemical Genetics
Laboratory, AKUH (2013-2014).
Organic Aciduria: n = 41 (47%)
Methyl CoA mutase deficiency 9 (10.2%)
MHBD 5 (5.7%)
HMG CoA lyase deficiency 4 (4.5%)
Propionic aciduria 4 (4.5%)
Isovaleric aciduria 3 (3.4%)
Multiple carboxylase deficiency 3 (3.4%)
Fructose-1, 6-biphosphatase deficiency 3 (3.4%)
Fumarase deficiency 3 (3.4%)
Glutaric aciduria type 1 3 (3.4%)
Suspected MMA 2 (2.3%)
Ethylmalonic aciduria 2 (2.3%)
Amino Acidopathies: n = 28 (32%)
MSUD 8 (9.1%)
CBS deficiency 6 (6.8%)
Urea cycle disorders 6 (6.8%)
Hyperphenylal aninemia 5 (5.7%)
Hyperprolinemia 3 (3.4%)
Others: n = 19 (21.6%)
Intracellular cobalamin defects 9 (10.2%)
Alkaptonuria 2 (2.3%)
Canavan's disease 2 (2.3%)
SUCL deficiency 2 (2.3%)
DPD deficiency 1 (1.1%)
AADC deficiency 1 (1.1%)
Glutaric aciduria type 2 1 (1.1%)
NKH 1 (1.1%)
MHBD = 2-methyl-3-hydroxybutyryl-CoA;   HMG CoA lyase = 3-hydroxy-3-methylglutaryl-
CoA;   MSUD = maple syrup urine disease;   CBS = cystathionine beta synthetase;
SUCL = succinate CoA ligase;   DPD = dihydropyrimidine;   AADC = aromatic amino acid
decarboxylase;   NKH = Non-ketotic hyperglycinemia.
Table II: Inherited metabolic disorders data from local studies.
Year Author Study Subjects Population Common Presentation IEM Testing Facility Common Inherited Disorders
1994 P. Multi et al.12 21 NICU patients with Karachi Neurological manifestation (76 %) India, UK UCDs, OA, MSUD, IVA and NKH
hyperammonemia
2008-2012 Afroze et al.7 426 patients Karachi Psychomotor retardation (36%) Kuala Lumpur, Malaysia. OA, PAA, Lysosomal storage disorders,
Seizures (23.7%) glycogen storage disorders
2009 H. satwani et al.13 62 outpatient children Karachi Developmental delays (47.6%) Japan OA and UCDs
from Pediatric clinic and respiratory distress (39.3%)
2013 S. Choudary et al.14 10 neonates Islamabad Seizures (50%) and Coma (50%) India MMA, NKH, Frutose-1,
6-bisphosphatase deficiency and 
Biotinidase deficiency
2011-14 Cheema HA et al. 15 239 Children Lahore Metabolic crisis (32.2%), liver failure Country not mentioned only Glycogen storage disorders,
<14 years (15.5%)  and mental retardation (13.3%) stated “diagnostic testing for Gaucher disease, galactosemia
metabolic disorders were and MPS
sent abroad”
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Overall, the frequency of OA as compared to AA is
higher in this study (47% vs. 33%) which is similar to
Japanese population (70% vs. 19%); whereas Malaysia,8
Singapore17 and Thailand18 showed increased frequency
of AA as compared to OA, i.e. 50% vs. 37%, 37% vs.
32%, 55% vs. 33%, respectively. When compared to the
incidence of IMDs with other Asian countries, Pakistan
has higher disease prevalence of IMDs (4.7%) as
compared to Singapore (3.5%), Japan (2.4%), and
Malaysia (2%). This variation in detection rates of IMDs
could be due to difference in the sample size and
consanguinity rate in these countries.16-18
For better outcome for treatable IMDs, early and correct
diagnosis is essential.19 Confirmatory testing, enzyme
assays, and/or molecular characterization after
suggestive biochemical diagnosis, will help in prenatal
genetic counselling and prenatal genetic diagnosis for
the couple at risk. Carrier screening for at risk family
members followed by genetic counselling for married
couples and pre-marital genetic counselling for carrier to
make informed decisions to choose their partners will
help in reducing the overall burden of AR IMDs in
Pakistan. These diagnostic modalities involve heavy
investment, expertise and robust healthcare to support
the service.20 Apart from this, high-risk screening for
IMDs provides important insight into the disease pattern
of a country, which can provide critical information
required for the selection of the most prevalent IMDs, to
be included in the national newborn screening for IMDs.
Thus, efforts to establish more diagnostic facilities and
allocation of national funds and resources to address the
common IMDs can be a way forward in strengthening
the IMD services and hope for patients and families
fighting with IMDs in Pakistan.
CONCLUSION
This study presents frequency of OA and AA in the high-
risk Pakistani pediatric population through selective
high-risk screening in symptomatic patients. Local
availability to the diagnosis of OA and AA increases the
access to patients and physicians, leading to timely
diagnosis and saving critical time to initiate timely
disease-specific treatment, leading to eventual better
management and effective genetic counselling. This
locally generated data will be helpful in planning and
providing services for patients with IMDs, including newborn
screening.
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